Bertelli A, Cerrati A, Giovannini L, Mian M, Spaggiari P, Bertelli AA
Patients on tirzepatide (Zepbound) have seen upward of 20% total body weight loss, whereas semaglutide (Wegovy) averages around 15%
Tirzepatide , the active ingredient in both Mounjaro and Zepbound is currently being evaluated in phase 3 trials for cardiovascular outcomes in diabetes patients, heart failure with preserved ejection fraction, morbidity and mortality in obesity, and obstructive sleep apnea (OSA)
Glutathione (-L-glutamyl-L-cysteinylglycine, GSH) is a major antioxidant acting as a free radical scavenger that protects the cell from reactive oxygen species (ROS)
Qualitative research consistently shows that individuals with obesity often report long-standing experiences of devaluation or exclusion, contributing to shame-based self-representations and defensive patterns such as withdrawal or minimization [82,83,84,85]
28 Fluid loss due to EDKA can range from 6 L to 9 L, and rehydration is necessary for adequate tissue perfusion and resolution of metabolic abnormalities